Dr. Tennican is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
665 N. Riverpoint Blvd.
Suite 410
Spokane, WA 99202Phone+1 509-994-4423Fax+1 509-443-7036
Summary
- Patrick Tennican, MD, based in Spokane, WA, is a specialist in Infectious Disease. He completed his medical education at the University of Washington School of Medicine in 1965, followed by an internship in Internal Medicine at Boston University Medical Center. His residency was completed at the University of Washington, where he also pursued a fellowship in Infectious Disease. Dr. Tennican serves as the CEO of Hyprotek, Inc. He has contributed several publications to the field, including studies on trichinellosis and antifungal therapies, with some being cited over 30 times.
Education & Training
- University of WashingtonFellowship, Infectious Disease, 1973 - 1975
- University of WashingtonResidency, Internal Medicine, 1970 - 1973
- Boston University Medical CenterInternship, Internal Medicine, 1965 - 1966
- University of Washington School of MedicineClass of 1965
Certifications & Licensure
- WA State Medical License 1970 - 2026
- AZ State Medical License 1974 - 2024
- CA State Medical License 1970 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 31 citationsOutbreak of Trichinellosis Associated with Eating Cougar JerkyMark S. Dworkin, H. Ray Gamble, Dante S. Zarlenga, Patrick O. Tennican
The Journal of Infectious Diseases. 1996-09-01 - 29 citationsLimited Toxicity of Prolonged Therapy with High Doses of Amphotericin B Lipid ComplexSusan Kline, Tom A. Larsen, Leonard Fieber, Ronald Fishbach, Martha Greenwood
Clinical Infectious Diseases. 1995-11-01 - 34 citationsKetoconazole treatment of nonprimary coccidioidomycosis: Evaluation of 60 patients during three years of study☆Richard DeFelice, John N. Galgiani, Sammy C. Campbell, Samuel D. Palpant, Barry A. Friedman
The American Journal of Medicine. 1982-04-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: